Elderberry for Antioxidant Support

Research suggests that elderberry contains bioactive compounds — particularly anthocyanins and flavonoids such as cyanidin 3-O-glucoside, luteolin, and myricetin — that demonstrate antioxidant activity in laboratory analyses. A 2024 metabolomics study examining 21 varieties of American elderberry identified 32 putative compounds and found measurable antioxidant capacity across multiple assays, though these were in vitro findings and do not directly establish effects in humans. A small open-label randomized clinical trial from 2022 involving 74 adults recovering from mild-to-moderate COVID-19 reported that a standardized elderberry extract was associated with greater reductions in lingering symptoms and improved quality of life scores compared to standard care alone, which may reflect broader antioxidant and anti-inflammatory properties, though the study's open-label design and small sample size limit how confidently these results can be interpreted. Overall, the available evidence is preliminary and skewed toward laboratory and small clinical studies, meaning larger, well-controlled human trials would be needed to more firmly establish elderberry's role in antioxidant support.